Brooker talks to Carlene McMaugh about the top stories from last year, including “the unicorn of 2023” – double dispensing – and the way it came as a shock to the profession.

“Most people were incredibly concerned about the impact of 60-day dispensing,” he says, saying that as a result, feedback to the AJP included “a lot more concern than we get most years. Probably even getting to the stage of fear. Fear over the future, fear over job security, fear over financial security and I think, fear over the future of pharmacy in general”.

Also coming to the fore last year were issues of funding, particularly that affecting the livelihood of consultant pharmacists working in aged care.

Brooker says our top two stories both covered specific medicines, and chats about his predictions for 2024, including the importance of the 8CPA and potential consequences of the Chemist Warehouse-Sigma merger.

And he also has some sentiments to share for members of the profession – and an invitation to tell us your stories.

Go here for the full list of active AJP podcasts. These can also be accessed via Apple Podcasts and Spotify